
Because zzso obesity may hinder medication compliance, it would be a reasonable approach to consider zzso drugs zzso that promote weight loss in overweight zzso We performed an zzso zzso study to assess the effects of zzso on weight in overweight female zzso zzso In particular, we studied how the zzso serum zzso level is related to changes in the weight of these zzso We recruited female zzso patients with zzso body mass index 25 or zzso Laboratory findings including serum zzso level were measured and zzso was administered as a zzso at a dose of 200 to zzso Six months later, we measured changes in the body zzso zzso female zzso patients enrolled in the study, and 23 of them completed the zzso Weight loss after zzso treatment was correlated with initial body weight zzso follow-up weight zzso and zzso serum zzso level zzso but was not correlated with patients' age, results of zzso profile, and dosage of zzso The correlation of the serum zzso level with weight loss was still significant after the effect of the initial weight was adjusted zzso Our study shows that low serum zzso level is associated with weight loss in overweight female zzso zzso This result may be beneficial for selecting zzso and provide clues for the zzso of zzso weight zzso 

